Fischer Medical Ventures Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹-7 Cr
QMar 2026
Quarterly Results

In Mar 2026, Fischer Medical Ventures (FISCHER) reported revenue ₹99 Cr and net profit ₹-7 Cr — revenue +102.0% YoY. For annual financials, live price and key ratios, visit Fischer Medical Ventures share price chart.

FISCHER Quarterly Results — Revenue, Profit & EPS Highlights

Fischer Medical Ventures latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Browse Fischer Medical Ventures annual reports for revenue, profit, balance sheet and cash flow data.

  • Revenue of ₹99 Cr in Mar 2026 (+11.2% vs Sept 2025, +102.0% vs Mar 2025)
  • Net Profit of ₹-7 Cr in Mar 2026 (-150.0% vs Sept 2025, -800.0% vs Mar 2025)
  • EBITDA of ₹2 Cr in Mar 2026 (-89.5% vs Sept 2025)
  • Operating Margin of 1.0% in Mar 2026 (-18.0pp vs Sept 2025)
  • Earnings Per Share of ₹-0.11 in Mar 2026 (-150.0% vs Sept 2025)

Fischer Medical Ventures Quarterly Results — Revenue, EBITDA, Net Profit & EPS

FISCHER quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 QoQ YoY
Revenue (₹ Cr) 99 89 49 31 102 11.2% 102.0%
Net Profit (₹ Cr) -7 14 1 5 19 - -
EBITDA (₹ Cr) 2 19 3 12 23 - -
EPS (₹) -0.11 0.22 -0.05 0.77 0.30 - -
Operating Margin (%) 1.0% 19.0% 5.0% 18.0% 21.0% - -

FISCHER Share Price Trend — 1-Year Movement Across Quarterly Results

Fischer Medical Ventures 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore Fischer Medical Ventures share price performance to track price trends across different timeframes.

Profitability Ratios

Profit Margin -7.1%
EBITDA Margin 2.0%
Operating Margin 1.0%
ROE (Annual) -7.3%

Balance Sheet Highlights

Total Assets ₹672 Cr
Total Equity ₹385 Cr
Current Assets ₹414 Cr
Current Liabilities ₹27 Cr

Cash Flow Analysis

Operating Cash Flow ₹-87 Cr
Investing Cash Flow ₹-125 Cr
Financing Cash Flow ₹315 Cr
Net Cash Flow ₹103 Cr

Current Market Data

Current Price ₹37.94
Exchange NSE
Last Updated Jul 24, 2026

FISCHER vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Fischer Medical Ventures latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026
₹163,719.34 Cr 1570.9 3,648 584 +1.2% +13.2% 16.0% 276.1
SRF
Mar 2026
₹81,872.54 Cr 2664.7 4,557 582 +28.0% +7.2% 12.8% 135.7
Coromandel Internat…
Mar 2026
₹60,014.83 Cr 1980.8 6,068 115 -37.9% +11.1% 1.9% 417.0
Linde
Mar 2026
₹59,771.45 Cr 6731.0 621 77 -4.5% +2.6% 12.4% 741.3
Fertilisers & Chemi…
Sept 2025
₹52,674.89 Cr 809.3 1,681 21 +48.8% - 1.2% 2529.1
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores